1. Home
  2. KELYA vs ABEO Comparison

KELYA vs ABEO Comparison

Compare KELYA & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kelly Services Inc.

KELYA

Kelly Services Inc.

N/A

Current Price

$15.88

Market Cap

340.1M

ML Signal

N/A

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

N/A

Current Price

$5.42

Market Cap

399.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KELYA
ABEO
Founded
1946
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.1M
399.5M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
KELYA
ABEO
Price
$15.88
$5.42
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$15.00
$20.00
AVG Volume (30 Days)
267.7K
1.5M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
3.07%
N/A
EPS Growth
N/A
165.16
EPS
0.15
N/A
Revenue
$5,355,600,000.00
$2,998,000.00
Revenue This Year
N/A
$1,024.31
Revenue Next Year
$4.60
$145.42
P/E Ratio
$106.40
N/A
Revenue Growth
N/A
258.18
52 Week Low
$7.98
$4.00
52 Week High
$17.75
$7.65

Technical Indicators

Market Signals
Indicator
KELYA
ABEO
Relative Strength Index (RSI) 46.63 34.08
Support Level $14.53 $4.91
Resistance Level $16.50 $5.52
Average True Range (ATR) 0.49 0.20
MACD -0.21 -0.04
Stochastic Oscillator 14.04 19.31

Price Performance

Historical Comparison
KELYA
ABEO

About KELYA Kelly Services Inc.

Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: